In our study, the expression level of EIF4E3 was significantly decreased in the BRCA group, indicating that EIF4E3 may function as a tumor suppressor gene in breast cancer, and its low expression may be associated with the progression of the disease. This evidence concerns the gene EIF4E3 and neoplasm.